The Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Centre, Düsseldorf, Germany.
J Cell Mol Med. 2010 Sep;14(9):2223-34. doi: 10.1111/j.1582-4934.2010.01141.x.
Obesity, insulin resistance and the metabolic syndrome, are characterized by expansion and inflammation of adipose tissue, including the depots surrounding the heart and the blood vessels. Epicardial adipose tissue (EAT) is a visceral thoracic fat depot located along the large coronary arteries and on the surface of the ventricles and the apex of the heart, whereas perivascular adipose tissue (PVAT) surrounds the arteries. Both fat depots are not separated by a fascia from the underlying tissue. Therefore, factors secreted from epicardial and PVAT, like free fatty acids and adipokines, can directly affect the function of the heart and blood vessels. In this review, we describe the alterations found in EAT and PVAT in pathological states like obesity, type 2 diabetes, the metabolic syndrome and coronary artery disease. Furthermore, we discuss how changes in adipokine expression and secretion associated with these pathological states could contribute to the pathogenesis of cardiac contractile and vascular dysfunction.
肥胖、胰岛素抵抗和代谢综合征的特征是脂肪组织的扩张和炎症,包括围绕心脏和血管的脂肪库。心外膜脂肪组织(EAT)是一种位于大冠状动脉周围以及心室表面和心脏顶点的内脏性胸部脂肪库,而血管周围脂肪组织(PVAT)则围绕动脉。这两个脂肪库与下面的组织没有筋膜隔开。因此,从心外膜和 PVAT 分泌的因子,如游离脂肪酸和脂肪因子,可以直接影响心脏和血管的功能。在这篇综述中,我们描述了在肥胖、2 型糖尿病、代谢综合征和冠状动脉疾病等病理状态下,EAT 和 PVAT 中发现的改变。此外,我们还讨论了与这些病理状态相关的脂肪因子表达和分泌的变化如何有助于心脏收缩和血管功能障碍的发病机制。